ZABBIO
DEAD

Serial Number

87628754

Owner

ZabBio, Inc.

Attorney

Paul Nardulli

Filing Date

Sep 29, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ZABBIO Trademark

Serial Number: 87628754

ZABBIO is a trademark filed by ZabBio, Inc. on September 29, 2017. The trademark is classified under Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ZabBio, Inc.

6160 Lusk Boulevard, Suite C105
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

September 29, 2017

Registration Date

Not Registered

Published for Opposition

April 2, 2019

Goods & Services

Diagnostic reagents for scientific or research use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagents for chemical analysis, other than for medical or veterinary purposes; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for use in infectious disease research

Contraceptive apparatus; Intra uterine contraceptive devices; Contraceptive vaginal rings; Medical apparatus for introducing pharmaceutical preparations into the human body

Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, viral and infectious diseases, cancer, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, sexually transmitted infections including, but not limited to, HIV, HPV, and herpes and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, urological preparations, contraceptives, ophthalmologic preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices; medical and scientific research, namely, conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Pharmaceutical research and development in relation to infectious disease prevention and therapy

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 29, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 29, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Nov 14, 2019 EXRA
SOU EXTENSION 1 GRANTED
Nov 12, 2019 EX1G
SOU EXTENSION 1 FILED
Nov 12, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 12, 2019 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 28, 2019 NOAM
PUBLISHED FOR OPPOSITION
Apr 2, 2019 PUBO
NOTICE OF PUBLICATION
Mar 13, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2019 TROA
NON-FINAL ACTION MAILED
Jan 31, 2019 CNRT
NON-FINAL ACTION WRITTEN
Jan 31, 2019 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 11, 2019 RCCK
ASSIGNED TO LIE
Jan 10, 2019 ALIE
LETTER OF SUSPENSION MAILED
May 17, 2018 CNSL
SUSPENSION LETTER WRITTEN
May 17, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2018 TROA
NON-FINAL ACTION MAILED
Jan 8, 2018 CNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2018 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 5, 2017 NWOS
NEW APPLICATION ENTERED
Oct 3, 2017 NWAP